Send Inquiry

Request To Call Back

ERLOCIP ARLOTINIB 150 MG TABLETS

Get a Price/Quote

ERLOCIP ARLOTINIB 150 MG TABLETS Specification

Pacakaging (Quantity Per Box)
30 tablets per box

Indication
Indicated for the treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer

Dosage Form
Tablet

Origin of Medicine
Indian

Salt Composition
Erlotinib Hydrochloride

Drug Type
Medicine Raw Materials

Ingredients
Erlotinib Hydrochloride

Physical Form
Tablets

Function
Anti-cancer (EGFR Inhibitor)

Recommended For
Non-Small Cell Lung Cancer (NSCLC) and Pancreatic Cancer Patients

Dosage
100mg , 150 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store below 30C, keep away from moisture and light

Patient Advice
Take on an empty stomach, at least 1 hour before or 2 hours after food. Avoid grapefruit juice while on therapy.

Shape
Round

Strength
150 mg

Shelf Life
24 months

Prescription/Non Prescription
Prescription

Colour
White to off-white

Tariff Code
30049099

Contraindications
Known hypersensitivity to Erlotinib or any excipients

Route of Administration
Oral

Side Effects
Rash, diarrhea, anorexia, fatigue, rare interstitial lung disease

Brand Name
ERLOCIP

Marketed By
Cipla Ltd.

ERLOCIP ARLOTINIB 150 MG TABLETS Trade Information

Packaging Details
Pack of 30 Tablets

Main Domestic Market
All India

About ERLOCIP ARLOTINIB 150 MG TABLETS

ERLOCIP 150 MG TABLETS - ERLOTINIB HYDROCHLORIDE

Erlocip Tablets Contains Erlotinib And Its Available As : 100 Mg & 150 Mg Tablets.

Specification :-

Product Name : Erlocip
Content : Erlotinib Hcl
Form : Tablets
Strength : 100 Mg & 150 Mg
Packing : Pack Of 30 Tablets
Manufactured By : Cipla

Note :-ErlocipIs A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............

How ERLOCIP ARLOTINIB Works

ERLOCIP 150 mg tablets contain Erlotinib Hydrochloride, which targets epidermal growth factor receptors (EGFR) to inhibit cancer cell growth. This mechanism is especially effective in certain types of non-small cell lung cancer and pancreatic cancer. By blocking EGFR signaling, ERLOCIP slows proliferation and may shrink tumors, offering a targeted approach to cancer treatment.

Usage Guidelines and Administration

Take ERLOCIP 150 mg tablets exactly as prescribed by your physician, typically on an empty stomachat least one hour before or two hours after food. Swallow the tablet whole with water. Avoid grapefruit juice, as it can alter medication effectiveness. Consistent daily use maximizes therapeutic benefits, so adhere closely to your prescribed schedule and dosage.

Safety Information and Side Effects

Common side effects of ERLOCIP may include rash, diarrhea, loss of appetite, and fatigue. Rare but serious reactions like interstitial lung disease can occur. The medicine is contraindicated for individuals hypersensitive to Erlotinib or any tablet ingredients. Promptly report unmanageable or severe symptoms to your healthcare provider for assessment.

FAQs of ERLOCIP ARLOTINIB 150 MG TABLETS:

Q: What is ERLOCIP ARLOTINIB 150 mg prescribed for?

A: ERLOCIP ARLOTINIB 150 mg is primarily indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer in adults. Consult your oncologist to determine if this targeted therapy is suitable for your condition.

Q: How should I take ERLOCIP 150 mg tablets for best results?

A: Take ERLOCIP on an empty stomach, either at least one hour before or two hours after eating. Swallow the tablet whole with water, and avoid grapefruit juice during your treatment to prevent interactions. Do not alter your prescribed dosage without consulting your doctor.

Q: What are the common side effects of ERLOCIP ARLOTINIB?

A: Some patients experience rash, diarrhea, decreased appetite, and fatigue. Rarely, serious lung-related side effects may occur. Notify your healthcare provider if you develop persistent or severe symptoms.

Q: When should ERLOCIP not be used?

A: ERLOCIP is contraindicated if you have a known hypersensitivity to Erlotinib or any of its excipients. Inform your doctor of any allergies or reactions to medicines before starting this therapy.

Q: Where should I store ERLOCIP tablets?

A: Store ERLOCIP tablets below 30C, away from moisture and light. Keep them in their original packaging and out of reach of children to maintain tablet integrity and safety.

Q: What is the benefit of using ERLOCIP for cancer treatment?

A: As an EGFR inhibitor, ERLOCIP directly targets molecular pathways involved in cancer cell growth, aiming to slow disease progression and improve patient outcomes in NSCLC and pancreatic cancer.

Q: Is a prescription required for ERLOCIP ARLOTINIB 150 mg?

A: Yes, ERLOCIP is a prescription-only medication. Treatment and dosage should be managed by a qualified healthcare professional based on your specific medical needs.

Tell us about your requirement